CRISPR/Cas9,Osr1

Ting-Yu Yeh1, Ing-Ming Chiu1,2,3,4, Yu-Jia Huang5

  • 1Doctoral Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung, 402, Taiwan.

Scientific reports
|November 4, 2025
PubMed
概括

通过胚胎囊补充生成小鼠脏显示出有前途. Osr1淘汰赛和胚胎干细胞注射导致了一些可行的仿真脏,表明器官生成的潜力.